Radiotherapy for Basal Cell Carcinoma



Basal cell carcinoma accounts for up to 80% of all non-melanoma skin cancers and is the most common cancer in the world. The primary aim of treatment for basal cell carcinomas is local control, as regional and distant spread is very rare. Although surgery remains the preferred modality for definitive treatment at most centers, radiotherapy is frequently considered for those patients who are medically inoperable and who have unresectable tumors or for those who decline surgery. Other relative indications for radiotherapy include cases where it would be difficult to achieve clear surgical margins and where surgery would result in unacceptable functional or cosmetic morbidity.


Basal cell carcinoma Radiotherapy Definitive radiotherapy Adjuvant radiotherapy Orthovoltage irradiation Electron beam therapy Intensity-modulated radiotherapy Volumetric modulated arc therapy Proton therapy Brachytherapy 


  1. 1.
    Porceddu SV. Prognostic factors and the role of adjuvant radiation therapy in non-melanoma skin cancer of the head and neck. Am Soc Clin Oncol Educ Book. 2015;35:e513–8.CrossRefGoogle Scholar
  2. 2.
    Cotran RS. Metastasizing basal cell carcinomas. Cancer. 1961;14:1036–40.CrossRefGoogle Scholar
  3. 3.
    Lakshmipathi T, Hunt KM. Metastasizing basal-cell carcinoma. Br J Dermatol. 1967;79:267–70.CrossRefGoogle Scholar
  4. 4.
    Scanlon EF, Volkmer DD, Oviedo MA, Khandekar JD, Victor TA. Metastatic basal cell carcinoma. J Surg Oncol. 1980;15:171–80.CrossRefGoogle Scholar
  5. 5.
    Hall VL, Leppard BJ, McGill J, Kesseler ME, White JE, Goodwin P. Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol. 1986;37:33–4.CrossRefGoogle Scholar
  6. 6.
    Avril MF, Auperin A, Margulis A, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer. 1997;76:100–6.CrossRefGoogle Scholar
  7. 7.
    Abbatucci JS, Boulier N, Laforge T, Lozier JC. Radiation therapy of skin carcinomas: results of a hypofractionated irradiation schedule in 675 cases followed more than 2 years. Radiother Oncol. 1989;14:113–9.CrossRefGoogle Scholar
  8. 8.
    Zagrodnik B, Kempf W, Seifert B, et al. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer. 2003;98:2708–14.CrossRefGoogle Scholar
  9. 9.
    Kwan W, Wilson D, Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys. 2004;60:406–11.CrossRefGoogle Scholar
  10. 10.
    van Hezewijk M, Creutzberg CL, Putter H, et al. Efficacy of a hypofractionated schedule in electron beam radiotherapy for epithelial skin cancer: analysis of 434 cases. Radiother Oncol. 2010;95:245–9.CrossRefGoogle Scholar
  11. 11.
    Cognetta AB, Howard BM, Heaton HP, Stoddard ER, Hong HG, Green WH. Superficial x-ray in the treatment of basal and squamous cell carcinomas: a viable option in select patients. J Am Acad Dermatol. 2012;67:1235–41.CrossRefGoogle Scholar
  12. 12.
    Krema H, Herrmann E, Albert-Green A, Payne D, Laperriere N, Chung C. Orthovoltage radiotherapy in the management of medial canthal basal cell carcinoma. Br J Ophthalmol. 2013;97:730–4.CrossRefGoogle Scholar
  13. 13.
    Rishi A, Hui Huang S, O’Sullivan B, et al. Outcome following radiotherapy for head and neck basal cell carcinoma with ‘aggressive’ features. Oral Oncol. 2017;72:157–64.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Peter MacCallum Cancer Centre, Department of Radiation OncologyMelbourneAustralia
  2. 2.The University of Texas MD Anderson Cancer Center, Department of Radiation Oncology-ResearchHoustonUSA
  3. 3.The University of Texas MD Anderson Cancer Center, Department of Radiation Oncology-TherapyHoustonUSA
  4. 4.The University of Texas MD Anderson Cancer Center, Department of Radiation OncologyHoustonUSA

Personalised recommendations